← Back to Patent Explorer
US4029672A Expired / Lapsed US ⏱️ 0.0 years remaining

Aminoalkylpyrrolobenzoxazalkanes

Assignee: CNA Holdings LLC
•
Filing: 1976-02-26
•
Granted: 1977-06-14
•
Expires: 1996-02-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel aminoalkylpyrrolobenzoxazalkanes, physiologically tolerable acid addition salts thereof, method of preparing same and novel intermediates in the preparation thereof are described. These compounds are useful as analgesic agents and tranquilizers.

Inventors

  • 👤 Richard C. Effland
  • 👤 Larry Davis
  • 👤 Wolfgang Schaub

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 22:10
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/30; C07D207/32; C07D207/33; C07D207/333; A; A61; A61P; A61P25/00; A61P25/04; A61P25/08; A61P25/20; A61P29/00; C07D207/335

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 148 words
A compound of the formula wherein Y is hydrogen, halogen, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms, trifluoromethyl, nitro or amino; R 1 is hydrogen or alkyl of 1 to 4 carbon atoms; R 2 is hydrogen, alkyl of from 1 to 5 carbon atoms, phenyl, cycloalkyl of from 3 to 6 carbon atoms, phenalkyl of the formula C 6 H 5 (CH 2 ) n --, or cycloakylalkyl of from 4 to 7 carbon atoms; R 3 is alkyl of from 1 to 5 carbon atoms, phenyl, cycloalkyl of from 3 to 6 carbon atoms, phenalkyl of the formula C 6 H 5 (CH 2 ) n --or cycloalkylalkyl of from 4 to 7 carbon atoms; m is the integer 1 or 2 and n is the integer 1, 2 or 3, or a physiologically tolerable acid addition salt thereof.
Claim 2
Dependent Claim 148 words
A compound of the formula wherein Y is hydrogen, halogen, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms, trifluoromethyl, nitro or amino; R 1 is hydrogen or alkyl of 1 to 4 carbon atoms; R 2 is hydrogen, alkyl of from 1 to 5 carbon atoms, phenyl, cycloalkyl of from 3 to 6 carbon atoms, phenalkyl of the formula C 6 H 5 (CH 2 ) n --, or cycloakylalkyl of from 4 to 7 carbon atoms; R 3 is alkyl of from 1 to 5 carbon atoms, phenyl, cycloalkyl of from 3 to 6 carbon atoms, phenalkyl of the formula C 6 H 5 (CH 2 ) n --or cycloalkylalkyl of from 4 to 7 carbon atoms; m is the integer 1 or 2 and n is the integer 1, 2 or 3, or a physiologically tolerable acid addition salt thereof.
Claim 3
Dependent Claim 17 words
A compound as defined in claim 1 of the formula ##STR4## wherein Y is hydrogen or halogen.
Claim 4
Dependent Claim 13 words
A compound as defined in claim 1 wherein m is the integer 1.
Claim 5
Dependent Claim 13 words
A compound as defined in claim 1 wherein m is the integer 2.
Claim 6
Dependent Claim 74 words
A compound as defined in claim 1 wherein Y is hydrogen chlorine; R 1 is hydrogen, methyl, ethyl or propyl; R 2 is hydrogen or straight or branched chain alkyl of from 1 to 4 carbon atoms; R 3 i straight or branched chain alkyl of from 1 to 4 carbon atoms, phenyl, phenalkyl of the formula C 6 H 5 (CH 2 ) n -or cycloalkyl of from 3 to 6 carbon atoms.
Claim 7
Dependent Claim 11 words
A compound as defined in claim 5 wherein n is 1.
Claim 8
Dependent Claim 11 words
A compound as defined in claim 5 wherein n is 2.
Claim 9
Dependent Claim 11 words
A compound as defined in claim 5 wherein n is 3.
Claim 10
Dependent Claim 16 words
A compound as defined in claim 1 wherein R 1 is hydrogen and n is 1.
Claim 11
Dependent Claim 10 words
The compound as defined in claim 1 which is 4-(ethylaminomethyl)-4H,10H-pyrrolo[2,1-c][1,4]benzoxazepine.
Claim 12
Dependent Claim 10 words
The compound as defined in claim 1 which is 4-(methylaminomethyl)-4H,10H-pyrrolo[2,1-c][1,4]benzoxazepine.
Claim 13
Dependent Claim 10 words
The compound as defined in claim 1 which is 4-(cyclopropylaminomethyl)-4H,10H-pyrrolo[2,1-c][1,4]benzoxazepine.
Claim 14
Dependent Claim 10 words
The compound as defined in claim 1 which is 4-(dimethylaminomethyl)-4H,10H-pyrrolo[2,1-c][1,4]benzoxazepine.
Claim 15
Dependent Claim 10 words
The compound as defined in claim 1 which is 4-(diethyl)aminomethyl)-4H,10H-pyrrolo[2,1-c][1,4]benzoxazepine.
Claim 16
Dependent Claim 22 words
The method of treating pain which comprises administering to a patient a pharmaceutically effective amount of a compound defined in claim 1.
Claim 17
Dependent Claim 25 words
A method of depressing the central nervous system which comprises administering to a patient a pharmaceutically effective amount of a compound defined in claim 1.
Claim 18
Dependent Claim 22 words
A method of treating convulsions which comprises administering to a patient a pharmaceutically effective amount of a compound defined in claim 1.
Claim 19
Dependent Claim 45 words
A pharmaceutical composition for treating pain or convulsions of depressing the central nervous system which comprises between about 0.5 and about 70 percent by weight of a compound defined in claim 1 as an essential active ingredient, the balance being a pharmaceutically accceptable carrier therefor.

References Cited (Backward Citations)

JPS4812756B1 Cited
DE2306605A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-06-13 1980-12-13 1981-06-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-06-13 1984-12-13 1985-06-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-06-13 1988-12-13 1989-06-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag